# AtheroNova Inc.: Form D filings

AtheroNova Inc., a pharmaceuticals company in Irvine, CA, filed 8 Form D notices with the SEC between 2010 and 2014. The latest, on September 16, 2014, reports $500,000 sold of a $1 million offering to 7 investors.

Find out what AtheroNova Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20AtheroNova%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=AtheroNova%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fatheronova-inc-1377053)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20AtheroNova%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=AtheroNova%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fatheronova-inc-1377053)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2301 DUPONT DRIVE, SUITE 525, Irvine, CA, 92612
- Phone: (949) 525-5471
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(c)
- SEC identifier (CIK): 1377053

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sep 16, 2014 | New notice | $1,000,000 | $500,000 | $500,000 | 7 | Sep 12, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705314000003/0001377053-14-000003-index.htm) |
| Mar 3, 2014 | Amendment | $2,000,000 | $1,906,500 | $93,500 | 31 | Jan 13, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705314000002/0001377053-14-000002-index.htm) |
| Jan 22, 2014 | New notice | $1,400,000 | $350,000 | $1,050,000 | 2 | Jan 13, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705314000001/0001377053-14-000001-index.htm) |
| Aug 21, 2013 | New notice | $4,000,000 | $270,000 | $3,730,000 | 3 | Aug 8, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705313000001/0001377053-13-000001-index.htm) |
| Nov 1, 2012 | New notice | $5,000,000 | $2,925,000 | $2,075,000 | 35 | Oct 1, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000143774912010831/0001437749-12-010831-index.htm) |
| Dec 20, 2011 | Amendment | $1,748,764 | $1,748,764 | $0 | 47 | Apr 10, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705311000002/0001377053-11-000002-index.htm) |
| May 12, 2011 | New notice | $1,000,000 | $437,725 | $562,275 | 7 | Apr 10, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705311000001/0001377053-11-000001-index.htm) |
| Jun 11, 2010 | New notice | $10,741,000 | $10,741,000 | $0 | 21 | May 13, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1377053/000137705310000004/0001377053-10-000004-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Alexander W Polinsky | Director |  |
| Thomas W Gardner | Executive Officer, Director |  |
| Johan M Spoor | Director |  |
| Paul W DiPerna | Director |  |
| Boris W Ratiner | Director |  |
| Gary W Freeman | Director |  |
| Mark Selawski | Executive Officer |  |
| Fred W Knoll | Director |  |
| Chaim W Davis | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Sep 15, 2014](https://specstream.ai/data/form-d/week/2014-09-15) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what AtheroNova Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).